Olaparib side effects

In clinical studies of olaparib, the most common adverse reactions reported in ≥10% of patients were nausea, fatigue, anemia, vomiting, diarrhea, decreased appetite, headache, dysgeusia, cough, neutropenia, dyspnea, dizziness, dyspepsia, leukopenia, and thrombocytopenia. After olaparib was put on the market, adverse events such as allergies (including angioedema), erythema nodosum, rash, and dermatitis occurred. In clinical studies of the combination treatment of olaparib and bevacizumab, common adverse reactions in ≥10% of patients were nausea, fatigue (including asthenia), anemia, lymphopenia, vomiting, diarrhea, neutropenia, leukopenia, urinary tract infection, and headache.